Contents

Acediasulfone

Chemical compound

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this articlebyintroducing citations to additional sources. Find sources: "Acediasulfone" – news · newspapers · books · scholar · JSTOR (March 2024)

Acediasulfone

Clinical data
ATC code	none
Identifiers
IUPAC name 2-([4-(4-aminophenyl)sulfonylphenyl]amino)acetic acid
CAS Number	80-03-5
PubChem CID	66451
DrugBank	DB08926 Y
ChemSpider	59823 Y
UNII	30YP2YHH8W
KEGG	D07061
ChEMBL	ChEMBL48396 Y
CompTox Dashboard (EPA)	DTXSID00229991
ECHA InfoCard	100.001.131
Chemical and physical data
Formula	C14H14N2O4S
Molar mass	306.34 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)NCC(=O)O
InChI InChI=1S/C14H14N2O4S/c15-10-1-5-12(6-2-10)21(19,20)13-7-3-11(4-8-13)16-9-14(17)18/h1-8,16H,9,15H2,(H,17,18) Y Key:FKKUMFTYSTZUJG-UHFFFAOYSA-N Y
(verify)

Acediasulfone (INN) is an antimicrobial drug, which also has antimalarial activity. It is a long-acting prodrugofdapsone, which is used for treating leprosy.

Synthesis[edit]

Dapsone is somewhat inconvenient to administer to patients because of its rather low water solubility.

In the search for more easily administered drugs, dapsone (1) was reacted with bromoacetic acid to give acediasulfone (2) which can be administered as a water-soluble salt.

References[edit]

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.